The aim of this study was to evaluate the incidence of secondary symptomatic vertebral compression fractures (VCFs) in patients previously treated by percutaneous vertebroplasty (VTP). Three hundred sixteen patients with 486 treated VCFs were included in the study according to the inclusion criteria. Patients were kept in regular follow-up using a standardized questionairre before, 1 day, 7 days, 6 months, and 1 year after, and, further on, on a yearly basis after VTP. The incidence of secondary symptomatic VCF was calculated, and anatomical distribution with respect to previous fractures characterized. Mean follow-up was 8 months (6-56 months) after VTP. Fifty-two of 316 (16.4 %) patients (45 female, 7 male) returned for treatment of 69 secondary VCFs adjacent to (35/69; 51%) or distant from (34/69; 49%) previously treated levels. Adjacent secondary VCF occurred significantly more often compared to distant secondary VCF. Of the total 69 secondary VCFs, 35 of 69 occurred below and 27 of 69 above pretreated VCFs. Of the 65 sandwich levels generated, in 7 of 65 (11%) secondary VCFs were observed. Secondary VCF below pretreated VCF occurred significantly earlier in time compared to VCF above and compared to sandwich body fractures. No major complication occurred during initial or follow-up intervention. We conclude that secondary VCFs do occur in individuals after VTP but the rate found in our study remains below the level expected from epidemiologic studies. Adjacent fractures occur more often and follow the cluster distribution of VCF as expected from the natural history of the underlying osteoporosis. No increased rate of secondary VCF after VTP was observed in this retrospective analysis. In accordance with the pertinent literature, short-term and also midterm clinical results are encouraging and provide further support for the usefulness and the low complication rate of this procedure as an adjunct to the spectrum of pain management in patients with severe midline back pain due to osteoporotic spine fractures.
Green acorns are known to contain high concentrations of pyrogallol. Here, we describe an extended case report of two pigeons found dead with a filled muscular stomach of acorns. The following pathologic findings were observed: irritation of mucosal membranes in the gastrointestinal tract, blackish discolored chyme, hyperemic organs, and general edemas. The muscular stomach (ventriculus) was filled with pieces of acorns, and the abdominal cavity contained bloody aqueous fluid. In order to uncover the cause of death, we determined pyrogallol in liver and kidney of one dead pigeon and in ventriculus contents of both pigeons by gas chromatography/mass spectrometry. A further aim of our study was to compare pathologic findings and pyrogallol concentrations in kidney, liver, and ventriculus of poisoned pigeons with those of healthy pigeons. The pyrogallol concentrations in samples of dead pigeons were 16-1200-fold higher than in control animals fed grass and maize-corn. Altogether, the acorn-filled ventriculus, the pathologic findings, the well nourished state, and the high pyrogallol concentrations in the dead pigeons suggest an acute pyrogallol poisoning by acorn. With respect to controls, we conclude that pyrogallol concentrations of 6 ng/g of kidney, 8 ng/g of liver, and 2 ng/g of gastric content do not affect the health of pigeons.
Operationsziel: Indirekte Reposition von subtrochantären Frakturen über die Ligamentotaxis ohne chirurgische Traumatisierung der Frakturzone (keine devaskularisierten Fragmente!) und übungsstabile Osteosynthese mit einer Kondylenplatte. Indikationen: Geschlossene und offene subtrochantäre Trümmerfrakturen des Femurs, insbesondere bei Beteiligung der Schenkelhalsbasis. Kontraindikationen: Keine, außer bei polytraumatisierten Patienten mit lebensbedrohlichen Verletzungen. Operationstechnik: Osteosynthese mit einer Kondylenplatte. Kapsulotomie, um die korrekte Position der Klinge zu prüfen. Reposition der Fraktur an den Schaft der Kondylenplatte unter Kontrolle von Länge, Rotation und Achse, aber ohne anatomische Reposition der einzelnen Fragmente. Kompression der Fraktur, falls möglich, mit dem Spanngerät. Weiterbehandlung: Frühe funktionelle Nachbehandlung mit 15 kg Teilbelastung ab zweitem postoperativen Tag. Ergebnisse: Von 1992 bis 1995 wurden 25 Patienten mit subtrochantärer Femurfraktur (Typ A: n=10; Typ B: n=8; Typ C: n=7 [nach AO-Klassifikation]; vier offene Frakturen) mit Kondylenplatte behandelt. Operationszeit: im Mittel 1,9 Stunden; intraoperativer Blutverlust: durchschnittlich 1300 ml. Normale Frakturheilung: 24/25 Patienten. Komplikationen: Infektpseudarthrose: n=1. Konsolidation der Fraktur nach mehrfachen Débridements und Reosteosynthese mit Wellenplatte. Achsenfehlstellungen: n=3 (Varus: n=2; Verkürzung: n=1; intertrochantäre Korrekturosteotomie: n=1). Entfernung der Platte wegen chronischer Trochanterirritation: n=2
In patients with chronic renal failure on potatoe-egg-diet (0.4 g protein/kg body weight) an alimentary vitamin B6-deficiency occurs, which can be overcome by 20 mg vitamin B6/day. Chronic hemodialysis causes a vitamin B6 loss which amounts to a quantity similar to the daily urinary excretion in normal persons. No hints for an inhibition of the synthesis of pyridoxal phosphate could be found.
Operationsziel: Indirekte Reposition von subtrochantären Frakturen über die Ligamentotaxis ohne chirurgische Traumatisierung der Frakturzone (keine devaskularisierten Fragmente!) und übungsstabile Osteosynthese mit einer Kondylenplatte. Indikationen: Geschlossene und offene subtrochantäre Trümmerfrakturen des Femurs, insbesondere bei Beteiligung der Schenkelhalsbasis. Kontraindikationen: Keine, außer bei polytraumatisierten Patienten mit lebensbedrohlichen Verletzungen. Operationstechnik: Osteosynthese mit einer Kondylenplatte. Kapsulotomie, um die korrekte Position der Klinge zu prüfen. Reposition der Fraktur an den Schaft der Kondylenplatte unter Kontrolle von Länge, Rotation und Achse, aber ohne anatomische Reposition der einzelnen Fragmente. Kompression der Fraktur,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.